CovIran Plus elicits protective neutralization against Omicron: study

TEHRAN – Results of a study conducted by Iranian scientists show that the domestically-developed SARS-CoV-2 vaccine candidate, BIV1-CovIran Plus, produces neutralizing antibodies against the Omicron variant.